depot medroxyprogesterone acetate
Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
... on depot medroxyprogesterone acetate (DMPA) and the implications of its use in obese women, preweight and postweight loss following bariatric ...
8
Trace Elements Levels and Blood Pressure in Ghanaian Women Using Depot Medroxyprogesterone Acetate Contraceptive
... The contraceptive, depot medroxyprogesterone acetate (DMPA) has played a very important role in birth control over the past few decades. It has proven to be a reliable contraceptive with it failure ...
7
TRANSFORMING GROWTH FACTOR BETA OF TESTIS GERMINAL CELL IN GUINEA PIG (CAVIA PORCELLUS) AFTER EXPOSURE TO METHANOL EXTRACT OF THE SEEDS OF BITTER MELON (MOMORDICA CHARANTIA) AND DEPOT MEDROXYPROGESTERONE ACETATE
... with depot medroxyprogesterone acetate (DMPA) was better able to suppress spermatogenesis in mice [19,20] and rabbits so as to decrease the quantity and quality ...
6
Finding The Minimal Effective Dose of A Combination of Depot Medroxyprogesterone Acetate and Javanese Long Pepper for Male Contraception on Testicular Fertility Parameters in Male Sprague Dawley Rats.
... Minimal Depot Medroksiprogesteron Asetat dan Ekstrak Cabe Jawa terhadap Konsentrasi dan Viabilitas Spermatozoa serta Kadar Hormon Testosteron ...of depot medroxyprogesterone acetate and ...
13
Review of Contraception with Depot Medroxyprogesterone Acetate at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria
... used depot medroxyprogesterone acetate at the UPTH were retrieved and their data including the socio- demographic characteristics, side effects, reasons for family planning extracted, coded and ...
6
Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa
... (IPCs) depot medroxyprogesterone acetate (DMPA) and norethister- one oenanthate (NET-EN) are by far the most widely uti- lised contraceptives in South Africa, especially amongst younger users and ...
9
High-risk sexual behaviors while on depot medroxyprogesterone acetate as compared to oral contraception
... [3–5]. Depot medroxyprogesterone acetate users may differ from users of other methods or from non-contraceptors be- cause DMPA is a simple-to-use method well-suited to women with busy schedules, ...
6
Adolescent and covert family planning users’ experiences self-injecting contraception in Uganda and Malawi: implications for waste disposal of subcutaneous depot medroxyprogesterone acetate
... Adolescents, and those who covertly use family planning without their partners or families knowing, face barriers when using injectable contraceptives. These groups may benefit from giving themselves injections in home ...
13
Scaling up depot medroxyprogesterone acetate (DMPA): a systematic literature review illustrating the AIDED model
... [11] and toolkits to aid policymakers and practitioners in scaling up community-based access to injectables have also been produced [30-33]. By contrast, this paper seeks to synthesize e[r] ...
12
Use of contraceptive depot medroxyprogesterone acetate is associated with impaired cervicovaginal mucosal integrity
... This study demonstrates that DMPA use results in significant alteration in expression of ectocervical genes essential for mucosal barrier structure and function and, as predicted by func[r] ...
18
Abnormal uterine bleeding
... Depot medroxyprogesterone acetate: Intramuscular administration of a 150-mg dose of DMPA every 12 weeks is a suitable option for the management of ...
5
Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
... Abbreviations: CIC, combined injectable contraceptive; COC, combined oral contraceptive; DM, diabetes mellitus; DMPA, depot medroxyprogesterone acetate; DVT/PE, deep venous thrombosis/[r] ...
11
Association of intimate partner vasectomy, use of long acting progestogen based contraceptives and intra uterine contraceptive devices with risk of ovarian cancer
... The WHO Collaborative Study of Neoplasia and Steroid Contraceptives found no association between ever-use of depot medroxyprogesterone acetate DMPA and ovarian cancer, and showed no cons[r] ...
314
Acceptability and side effects of Cyclofem© once-a-month injectable contraceptive in Kerman, Iran
... Progestrone Acetate and 5 mg Estradiol Cypionate ...(depot medroxyprogesterone acetate) users found no difference between the two methods (10), and the main menstrual side effect of both ...
6
Heavy menstrual bleeding diagnosis and medical management
... AUB: Abnormal uterine bleeding; CHCs: Combination hormonal contraceptives; COX-2: Progesterone withdrawal increases endometrial cyclooxygenase 2; DMPA: Depot medroxyprogesterone acetate;[r] ...
8
Scale up use of family planning services to prevent maternal transmission of HIV among discordant couples: a cross-sectional study within a resource-limited setting
... with depot medroxyprogesterone acetate or norethisterone enanthate, and diaphragm (4%), while about 30% reported having previously used traditional methods such as withdrawal (32%), fertility ...
11
Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate
... rapid and predictable drug response is desired as in an emergency situation, when patient is uncooperative, unconscious, or unable to take drug via an enteral route and when localized drug therapy is required. MPA is a ...
5
Development And Validation Of Stability Indicating Hplc Method For Estimation Of Leuprolide Acetate In Its Parenteral Dosage Form
... produces the seminal fluid that nourishes and transports sperm. Leuprolide is a parenterally administered, gonadotropin releasing hormone (GnRH) agonist which causes an inhibition of estrogen and androgen production and ...
11
Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells
... AMPK: Activating AMP-activated protein kinase; ATCC: American Type Culture Collection; ATF6: Activating transcription factor 6; BP: Biological process; CC: Cellular component; CHOP: CCAAT/enhancer-binding protein ...
11
Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation
... Major databases (MEDLINE, EMBASE, and Cochrane) were systematically searched in September 2012 to identify studies of 1 M, 3 M and 6 M depot formulations of leuprolide acetate in the treatment of prostate ...
13